EAM Global Investors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,612
| Closed | -$3.13M | – | 101 |
|
|
2024
Q1 | $3.13M | Hold |
44,612
| – | – | 0.72% | 84 |
|
|
2023
Q4 | $3.72M | Buy |
+44,612
| New | +$3.72M | 0.9% | 63 |
|
|
2022
Q4 | – | Sell |
-105,202
| Closed | -$5.1M | – | 195 |
|
|
2022
Q3 | $5.1M | Hold |
105,202
| – | – | 1.35% | 6 |
|
|
2022
Q2 | $4.13M | Buy |
105,202
+14,477
| +16% | +$569K | 1.01% | 16 |
|
|
2022
Q1 | $3.34M | Sell |
90,725
-67,767
| -43% | -$2.49M | 0.62% | 40 |
|
|
2021
Q4 | $7.22M | Buy |
158,492
+45,065
| +40% | +$2.05M | 1.28% | 4 |
|
|
2021
Q3 | $4.05M | Buy |
+113,427
| New | +$4.05M | 0.96% | 14 |
|
|
2020
Q4 | – | Sell |
-45,185
| Closed | -$978K | – | 141 |
|
|
2020
Q3 | $978K | Sell |
45,185
-30,775
| -41% | -$666K | 0.36% | 123 |
|
|
2020
Q2 | $1.79M | Buy |
+75,960
| New | +$1.79M | 0.8% | 54 |
|